Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy

被引:0
|
作者
S Baulies
L Belin
P Mallon
C Senechal
J-Y Pierga
P Cottu
M-P Sablin
X Sastre
B Asselain
R Rouzier
F Reyal
机构
[1] Institut Curie,Department of Surgery
[2] 26 rue d'Ulm,Department of Biostatistics
[3] 75005 Paris,Department of Medical Oncology
[4] France,Department of Tumor Biology
[5] Institut Curie,Department of Translational Research
[6] 26 rue d'Ulm,undefined
[7] 75005 Paris,undefined
[8] France,undefined
[9] Craigavon Area Hospital Breast Unit,undefined
[10] Institut Curie,undefined
[11] 26 rue d'Ulm,undefined
[12] 75005 Paris,undefined
[13] France,undefined
[14] Institut Curie,undefined
[15] 26 rue d'Ulm,undefined
[16] 75005 Paris,undefined
[17] France,undefined
[18] Residual Tumor and Response to Treatment Lab,undefined
[19] RT2Lab,undefined
[20] Institut Curie,undefined
[21] 26 rue d'Ulm,undefined
[22] 75005 Paris,undefined
[23] France,undefined
[24] UMR932,undefined
[25] Immunity and Cancer,undefined
[26] Institut Curie,undefined
[27] 26 rue d'Ulm,undefined
[28] 75005 Paris,undefined
[29] France,undefined
来源
British Journal of Cancer | 2015年 / 113卷
关键词
prognostic factors; neoadjuvant chemotherapy; survival; time-varying effect; breast cancer; tumour subtype;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:30 / 36
页数:6
相关论文
共 50 条
  • [1] Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy
    Baulies, S.
    Belin, L.
    Mallon, P.
    Senechal, C.
    Pierga, J-Y
    Cottu, P.
    Sablin, M-P
    Sastre, X.
    Asselain, B.
    Rouzier, R.
    Reyal, F.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 113 (01) : 30 - 36
  • [2] LONG-TERM SURVIVAL OF PATIENTS WITH UNRESECTABLE COLORECTAL CANCER TREATED WITH NEOADJUVANT CHEMOTHERAPY
    Susana, Redondo
    Pilar, Modamio
    Salvador, Quintana
    Fernandez Cecilia, Lastra
    Eduardo L, Marino
    [J]. ATENCION FARMACEUTICA, 2012, 14 (04): : 238 - +
  • [3] Time-varying effects of prognostic factors associated with long-term survival in breast cancer
    Zhang, Minlu
    Peng, Peng
    Gu, Kai
    Cai, Hui
    Qin, Guoyou
    Shu, Xiao Ou
    Bao, Pingping
    [J]. ENDOCRINE-RELATED CANCER, 2018, 25 (05) : 509 - 521
  • [4] LONG-TERM SURVIVAL OF PATIENTS TREATED WITH COMBINATION CHEMOTHERAPY FOR METASTATIC BREAST-CANCER
    FALKSON, G
    TORMEY, DC
    CAREY, P
    WITTE, R
    FALKSON, HC
    [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 (08) : 973 - 977
  • [5] Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy
    Galvez, Marco
    Castaneda, Carlos A.
    Sanchez, Joselyn
    Castillo, Miluska
    Pamela Rebaza, Lia
    Calderon, Gabriela
    De La Cruz, Miguel
    Manuel Cotrina, Jose
    Abugattas, Julio
    Dunstan, Jorge
    Guerra, Henry
    Mejia, Omar
    Gomez, Henry L.
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2018, 9 (02): : 33 - 41
  • [6] Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients
    Yau, Christina
    Osdoit, Marie
    van der Noordaa, Marieke
    Shad, Sonal
    Wei, Jane
    de Croze, Diane
    Harny, Anne-Sophie
    Lae, Marick
    Reyal, Fabien
    Sonke, Gabes S.
    Steenbruggen, Tessa G.
    van Seijen, Maartje
    Wesseling, Jelle
    Martin, Miguel
    del Monte-Millan, Maria
    Lopez-Tarruella, Sara
    Boughey, Judy C.
    Goetz, Matthew P.
    Hoskin, Tanya
    Gould, Rebekah
    Valero, Vicente
    Edge, Stephen B.
    Abraham, Jean E.
    Bartlett, John M. S.
    Caldas, Carlos
    Dunn, Janet
    Earl, Helena
    Hayward, Larry
    Hiller, Louise
    Provenzano, Elena
    Sammut, Stephen-John
    Thomas, Jeremy S.
    Cameron, David
    Graham, Ashley
    Hail, Peter
    Mackintosh, Lorna
    Fan, Fang
    Godwin, Andrew K.
    Schwensen, Kelsey
    Sharma, Priyanko
    DeMichele, Angela M.
    Cole, Kimberly
    Pusztai, Lajos
    Kim, Mi-Ok
    Veer, Laura J. van't
    Esserman, Laura J.
    Symmans, W. Fraser
    [J]. LANCET ONCOLOGY, 2022, 23 (01): : 149 - 160
  • [7] Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival
    Schwartz, PE
    Rutherford, TJ
    Chambers, JT
    Kohorn, EI
    Thiel, RP
    [J]. GYNECOLOGIC ONCOLOGY, 1999, 72 (01) : 93 - 99
  • [8] Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy:: an updated analysis of a randomized trial
    Broët, P
    Scholl, SM
    de la Rochefordière, A
    Fourquet, A
    Moreau, T
    De Rycke, Y
    Asselain, B
    Pouillart, P
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1999, 58 (02) : 151 - 156
  • [9] Classifications of Pathological Response and Long-Term Follow-Up in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Corben, A. D.
    Teo, C.
    AbiRaad, R.
    Bombonati, A.
    Koerner, F. C.
    Taghian, A.
    Brachtel, E. F.
    [J]. MODERN PATHOLOGY, 2011, 24 : 34A - 35A
  • [10] Classifications of Pathological Response and Long-Term Follow-Up in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Corben, A. D.
    Teo, C.
    AbiRaad, R.
    Bombonati, A.
    Koerner, F. C.
    Taghian, A.
    Brachtel, E. F.
    [J]. LABORATORY INVESTIGATION, 2011, 91 : 34A - 35A